Cargando…
Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss
Osteoclastogenesis is an essential process during bone metabolism which can also be promoted by inflammatory signals. Thrombomodulin (TM), a transmembrane glycoprotein, exerts anti-inflammatory activities such as neutralization of proinflammatory high-mobility group box 1 (HMGB1) through TM lectin-l...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911607/ https://www.ncbi.nlm.nih.gov/pubmed/27311356 http://dx.doi.org/10.1038/srep28340 |
_version_ | 1782438158074380288 |
---|---|
author | Cheng, Tsung-Lin Lai, Chao-Han Shieh, Shyh-Jou Jou, Yin-Bo Yeh, Jwu-Lai Yang, Ai-Lun Wang, Yan-Hsiung Wang, Chau-Zen Chen, Chung-Hwan Shi, Guey-Yueh Ho, Mei-Ling Wu, Hua-Lin |
author_facet | Cheng, Tsung-Lin Lai, Chao-Han Shieh, Shyh-Jou Jou, Yin-Bo Yeh, Jwu-Lai Yang, Ai-Lun Wang, Yan-Hsiung Wang, Chau-Zen Chen, Chung-Hwan Shi, Guey-Yueh Ho, Mei-Ling Wu, Hua-Lin |
author_sort | Cheng, Tsung-Lin |
collection | PubMed |
description | Osteoclastogenesis is an essential process during bone metabolism which can also be promoted by inflammatory signals. Thrombomodulin (TM), a transmembrane glycoprotein, exerts anti-inflammatory activities such as neutralization of proinflammatory high-mobility group box 1 (HMGB1) through TM lectin-like domain. This study aimed to identify the role of myeloid TM (i.e., endogenous TM expression on the myeloid lineage) in osteoclastogenesis and inflammatory bone loss. Using human peripheral blood mononuclear cells and mouse bone marrow-derived macrophages, we observed that the protein levels of TM were dramatically reduced as these cells differentiated into osteoclasts. In addition, osteoclastogenesis and extracellular HMGB1 accumulation were enhanced in primary cultured monocytes from myeloid-specific TM-deficient mice (LysMcre/TM(flox/flox)) and from TM lectin-like domain deleted mice (TM(LeD/LeD)) compared with their respective controls. Micro-computerized tomography scans showed that ovariectomy-induced bone loss was more pronounced in TM(LeD/LeD) mice compared with controls. Finally, the inhibiting effects of recombinant TM lectin-like domain (rTMD1) on bone resorption in vitro, and bone loss in both the ovariectomized model and collagen antibody-induced arthritis model has been detected. These findings suggested that the myeloid TM lectin-like domain may inhibit osteoclastogenesis by reducing HMGB1 signaling, and rTMD1 may hold therapeutic potential for inflammatory bone loss. |
format | Online Article Text |
id | pubmed-4911607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-49116072016-06-17 Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss Cheng, Tsung-Lin Lai, Chao-Han Shieh, Shyh-Jou Jou, Yin-Bo Yeh, Jwu-Lai Yang, Ai-Lun Wang, Yan-Hsiung Wang, Chau-Zen Chen, Chung-Hwan Shi, Guey-Yueh Ho, Mei-Ling Wu, Hua-Lin Sci Rep Article Osteoclastogenesis is an essential process during bone metabolism which can also be promoted by inflammatory signals. Thrombomodulin (TM), a transmembrane glycoprotein, exerts anti-inflammatory activities such as neutralization of proinflammatory high-mobility group box 1 (HMGB1) through TM lectin-like domain. This study aimed to identify the role of myeloid TM (i.e., endogenous TM expression on the myeloid lineage) in osteoclastogenesis and inflammatory bone loss. Using human peripheral blood mononuclear cells and mouse bone marrow-derived macrophages, we observed that the protein levels of TM were dramatically reduced as these cells differentiated into osteoclasts. In addition, osteoclastogenesis and extracellular HMGB1 accumulation were enhanced in primary cultured monocytes from myeloid-specific TM-deficient mice (LysMcre/TM(flox/flox)) and from TM lectin-like domain deleted mice (TM(LeD/LeD)) compared with their respective controls. Micro-computerized tomography scans showed that ovariectomy-induced bone loss was more pronounced in TM(LeD/LeD) mice compared with controls. Finally, the inhibiting effects of recombinant TM lectin-like domain (rTMD1) on bone resorption in vitro, and bone loss in both the ovariectomized model and collagen antibody-induced arthritis model has been detected. These findings suggested that the myeloid TM lectin-like domain may inhibit osteoclastogenesis by reducing HMGB1 signaling, and rTMD1 may hold therapeutic potential for inflammatory bone loss. Nature Publishing Group 2016-06-17 /pmc/articles/PMC4911607/ /pubmed/27311356 http://dx.doi.org/10.1038/srep28340 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Cheng, Tsung-Lin Lai, Chao-Han Shieh, Shyh-Jou Jou, Yin-Bo Yeh, Jwu-Lai Yang, Ai-Lun Wang, Yan-Hsiung Wang, Chau-Zen Chen, Chung-Hwan Shi, Guey-Yueh Ho, Mei-Ling Wu, Hua-Lin Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
title | Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
title_full | Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
title_fullStr | Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
title_full_unstemmed | Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
title_short | Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
title_sort | myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911607/ https://www.ncbi.nlm.nih.gov/pubmed/27311356 http://dx.doi.org/10.1038/srep28340 |
work_keys_str_mv | AT chengtsunglin myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT laichaohan myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT shiehshyhjou myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT jouyinbo myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT yehjwulai myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT yangailun myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT wangyanhsiung myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT wangchauzen myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT chenchunghwan myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT shigueyyueh myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT homeiling myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss AT wuhualin myeloidthrombomodulinlectinlikedomaininhibitsosteoclastogenesisandinflammatoryboneloss |